SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-057447
Filing Date
2018-09-18
Accepted
2018-09-18 16:16:38
Documents
4
Period of Report
2018-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-27129_58k.htm 8-K 47643
2 EX-1.1 a18-27129_5ex1d1.htm EX-1.1 281561
3 EX-4.2 a18-27129_5ex4d2.htm EX-4.2 378775
4 EX-5.1 a18-27129_5ex5d1.htm EX-5.1 19813
  Complete submission text file 0001104659-18-057447.txt   729081
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 181075865
SIC: 2834 Pharmaceutical Preparations